{"title": "Pharmacokinetic properties of wogonin and its herb-drug interactions with docetaxel in rats with mammary tumors - PubMed", "author": "Username", "url": "https://pubmed.ncbi.nlm.nih.gov/29679509/", "hostname": "ncbi.nlm.nih.gov", "description": "Docetaxel, frequently used for the treatment of breast cancer, is mainly metabolized via hepatic cytochrome P450 (CYP) 3A in humans and is also a substrate of P-glycoprotein (P-gp). Wogonin has been shown to be able to modulate the activities of CYPs and P-gp, and it could serve as an adjuvant chemo ...", "sitename": "PubMed", "date": "2018-04-21", "cleaned_text": "activities of CYPs their pharmacokinetics have not been studied because of a lack of an analytical method for their simultaneous measurement. In the for simultaneous measurement of wogonin and docetaxel in rat plasma, and it was then utilized to explore the pharmacokinetics of wogonin and rats 20 and 40 mg/kg via oral administration, with or without docetaxel intravenously administered at 10 mg/kg, and the plasma the wogonin. increased co-administration (p < 0.05), increased of wogonin and docetaxel, might lead to - pharmacokinetics Ethnopharmacol. - [Effects of morin - [Danshen "}